IP Library Granted Patent US 9,403,884
Granted Patent B2
US 9,403,884 · App. 13/557,706 · Granted Aug 2, 2016

Peptides useful as cell-penetrating peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,403,884
App. No.
13/557,706
Granted
Aug 2, 2016
Kind
B2
Abstract

A peptide having an amino acid sequence containing at least eight consecutive amino acids of the human lactoferrin protein or of the bovine lactoferrin protein. The peptide is suitable as a cell-penetrating peptide. A complex of the peptide and a cargo molecule non-covalently bound to the peptide. The cargo molecule may be a nucleic acid, an amino acid, a peptide, a protein, a carbohydrate, a lipid, or a small molecule. A method of penetrating or transfecting a cell using the complex.

Claims (16)

1. A complex, comprising:

(A) a peptide consisting of SEQ ID NO:3 and which is not-labeled with a radioactive label or a hapten; and

(B) a cargo molecule non-covalently bound to the peptide, wherein the non-covalent bond is an ionic bond, a hydrogen bond, or a hydrophobic interaction.

2. The complex of claim 1 , wherein the cargo molecule is at least one selected from the group consisting of a nucleic acid, an amino acid, a peptide, a protein, a carbohydrate, a lipid, and a small molecule.

3. The complex of claim 1 , wherein the cargo molecule is present as or part of a structure,

wherein the structure is selected from the group consisting of nanoparticles, microparticles, liposomes, and micelles.

4. The complex of claim 2 , wherein the nucleic acid is a nucleic acid selected from the group consisting of DNA molecules, RNA molecules, PNA molecules, siRNA molecules, antisense molecules, ribozymes, aptamers, spiegelmers, and decoy molecules.

5. The complex of claim 2 , wherein the cargo molecule is a peptide intended for use as a vaccine.

6. The complex of claim 2 , wherein the nucleic acid is a nucleic acid-based vaccine.

7. The complex of claim 3 , wherein the structure is at least one of the nanoparticles and the microparticles and the at least one of the nanoparticles and the microparticles comprise a pharmaceutically active compound.

8. The complex of claim 7 , wherein at least one of the nanoparticles and the microparticles consist of a pharmaceutically active compound.

9. The complex of claim 1 ,

wherein the cargo molecule is a small molecule having a molecular weight of 1000 D or less and is a drug or a drug candidate non-covalently bound to the peptide.

10. A complex, consisting of:

(A) a peptide consisting of SEQ ID NO:3; and

(B) a cargo molecule non-covalently bound to the peptide, wherein the non-covalent bond is an ionic bond, a hydrogen bond, or a hydrophobic interaction.

Assignments (3)
CHANGE OF NAME Recorded Feb 11, 2020
From: EVONIK ROEHM GMBH
To: ROEHM GMBH
Reel/Frame 051893/0671 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2020
From: ROEHM GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 051893/0727 →
CHANGE OF NAME Recorded Feb 11, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051894/0001 →